La Prensa MedicaISSN: 0032-745X

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

The effect of nanoparticle labeled bone marrow-derived mesenchymal stem cells as a therapeutic strategy for experimentally induced liver fibrosis in albino rats

Objectives: This study aims at exploring the therapeutic efficacy of
superparamagnetic iron oxide nanoparticles (SPIO) labeled bone
marrow derived mesenchymal stem cells (BM-MSCs) on carbon
tetrachloride (CCl4) induced liver fibrosis in adult female albino rats.
Material and methods: MSCs were obtained from 10 male Sprague
Dawley rats and 50 female rats were assigned into 2 groups; control
group (CG) and experimental group (EG). EG was subdivided into
three subgroups. Induction group by intraperitoneal injection of CCl4
for 8 weeks, MSCs treated + CCl4 group (MSCs+CCl4G) received
SPIO- BM-MSCs simultaneously with CCl4 administration to assess
the effect of SPIO-BM-MSCs on the prevention of progression of
liver fibrosis with the persistence of the cause. MSCs treated group
(MSCsG), received SPIO-BM-MSCs after withdrawal of CCl4. The
rats were sacrificed after 8 weeks and assessed by histological
examination, liver function tests, transforming growth factor-beta
(TGF-ß1) immunofluorescence staining, PCR for quantification of
the gene expression levels of matrix metalloproteinase-1(MMP-1)
and tissue inhibitor of metalloproteinase-1 (TIMP-1).
Results: SPIO labeled MSCs were engrafted in the fibrotic liver
and MSCs improved liver functions, enhanced the gene expression
of MMP-1, whereas TIMP1 gene expression was depressed.
Histological and morphometric studies confirmed these results.
Conclusion: BM-MSCs prove to be a promising therapy for liver

Special Features

Full Text


Track Your Manuscript

Media Partners